From simple to complex: Protein-based biomarker discovery in tuberculosis.

Autor: Mousavian Z; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden., Källenius G; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden., Sundling C; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Publikováno v: European journal of immunology [Eur J Immunol] 2023 Dec; Vol. 53 (12), pp. e2350485. Date of Electronic Publication: 2023 Oct 08.

Diagnostic markers reflecting dysregulation of the host response in the transition to tuberculosis disease.

Autor: Källenius G; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden., Correia-Neves M; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Life and Health Sciences Research Institute, School of Medicine, University of Minho, Braga, Portugal; ICVS/3B's, PT Government Associate Laboratory, Braga, Portugal., Sundling C; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden. Electronic address: christopher.sundling@ki.se.

Publikováno v: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Apr; Vol. 141S, pp. 106984. Date of Electronic Publication: 2024 Feb 28.

Dynamics of Penicillin-Susceptible Clones in Invasive Pneumococcal Disease

Autor: Normark, B. Henriques, Kalin, M., Ortqvist, Å., Åkerlund, T., Liljequist, B. Olsson, Hedlund, J., Svenson, S. B., Zhou, J., Spratt, B. G., Normark, S., Källenius, G.

Publikováno v: The Journal of Infectious Diseases, 2001 Oct 01. 184(7), 861-869.

Externí odkaz: https://www.jstor.org/stable/30137512

A protein signature associated with active tuberculosis identified by plasma profiling and network-based analysis.

Autor: Mousavian Z; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; School of Mathematics, Statistics and Computer Science, College of Science, University of Tehran, Tehran, Iran., Folkesson E; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden., Fröberg G; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Microbiology, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden., Foroogh F; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden., Correia-Neves M; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Life and Health Sciences Research Institute, School of Medicine, University of Minho, Braga, Portugal.; ICVS/3B's, PT Government Associate Laboratory, Braga, Portugal., Bruchfeld J; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden., Källenius G; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden., Sundling C; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.; Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden.

Publikováno v: IScience [iScience] 2022 Nov 22; Vol. 25 (12), pp. 105652. Date of Electronic Publication: 2022 Nov 22 (Print Publication: 2022).

Performance of novel antibodies for lipoarabinomannan to develop diagnostic tests for Mycobacterium tuberculosis.

Autor: Cantera JL; Diagnostics Program, PATH, Seattle, Washington, United States of America., Lillis LM; Diagnostics Program, PATH, Seattle, Washington, United States of America., Peck RB; Diagnostics Program, PATH, Seattle, Washington, United States of America., Moreau E; TB Program, FIND, Geneva, Switzerland., Schouten JA; Mologic, Thurleigh, Beds, United Kingdom., Davis P; Mologic, Thurleigh, Beds, United Kingdom., Drain PK; Departments of Global Health, Medicine, and Epidemiology, University of Washington, Seattle, Washington, United States of America., Andama A; College of Health Sciences, Makerere University, Kampala, Uganda., Pinter A; Public Health Research Institute Center, New Jersey Medical School, Rutgers University, New Brunswick, New Jersey, United States of America., Kawasaki M; Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan., Källenius G; Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet and Department of Infectious Diseases, Karolinska University Hospital, Solna, Sweden., Sundling C; Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet and Department of Infectious Diseases, Karolinska University Hospital, Solna, Sweden., Dobos KM; Mycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, United States of America., Flores D; Mycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, United States of America., Chatterjee D; Mycobacteria Research Laboratories, Department of Microbiology, Immunology, and Pathology, Colorado State University, Fort Collins, Colorado, United States of America., Murphy E; Diagnostics Program, PATH, Seattle, Washington, United States of America., Halas OR; Diagnostics Program, PATH, Seattle, Washington, United States of America., Boyle DS; Diagnostics Program, PATH, Seattle, Washington, United States of America.

Publikováno v: PloS one [PLoS One] 2022 Sep 30; Vol. 17 (9), pp. e0274415. Date of Electronic Publication: 2022 Sep 30 (Print Publication: 2022).